Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types
Abstract Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-020-00854-w |
_version_ | 1818030149777489920 |
---|---|
author | Yu-Tong Chen Jia-Yi Shen Dong-Ping Chen Chen-Fei Wu Rui Guo Pan-Pan Zhang Jia-Wei Lv Wen-Fei Li Zi-Xian Wang Yu-Pei Chen |
author_facet | Yu-Tong Chen Jia-Yi Shen Dong-Ping Chen Chen-Fei Wu Rui Guo Pan-Pan Zhang Jia-Wei Lv Wen-Fei Li Zi-Xian Wang Yu-Pei Chen |
author_sort | Yu-Tong Chen |
collection | DOAJ |
description | Abstract Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically performed a pan-cancer genomic analysis by depicting the molecular correlations between m6A and 5mC regulators across ~ 11,000 subjects representing 33 cancer types. For the first time, we identified cross-talk between m6A and 5mC methylation at the multiomic level. Then, we further established m6A/5mC epigenetic module eigengenes by combining hub m6A/5mC regulators and informed a comprehensive epigenetic state. The model reflected status of the tumor-immune-stromal microenvironment and was able to predict patient survival in the majority of cancer types. Our results lay a solid foundation for epigenetic regulation in human cancer and pave a new road for related therapeutic targets. |
first_indexed | 2024-12-10T05:31:00Z |
format | Article |
id | doaj.art-994786b145ba465b9d7b966534924918 |
institution | Directory Open Access Journal |
issn | 1756-8722 |
language | English |
last_indexed | 2024-12-10T05:31:00Z |
publishDate | 2020-03-01 |
publisher | BMC |
record_format | Article |
series | Journal of Hematology & Oncology |
spelling | doaj.art-994786b145ba465b9d7b9665349249182022-12-22T02:00:33ZengBMCJournal of Hematology & Oncology1756-87222020-03-011311510.1186/s13045-020-00854-wIdentification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer typesYu-Tong Chen0Jia-Yi Shen1Dong-Ping Chen2Chen-Fei Wu3Rui Guo4Pan-Pan Zhang5Jia-Wei Lv6Wen-Fei Li7Zi-Xian Wang8Yu-Pei Chen9State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer CenterAbstract Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically performed a pan-cancer genomic analysis by depicting the molecular correlations between m6A and 5mC regulators across ~ 11,000 subjects representing 33 cancer types. For the first time, we identified cross-talk between m6A and 5mC methylation at the multiomic level. Then, we further established m6A/5mC epigenetic module eigengenes by combining hub m6A/5mC regulators and informed a comprehensive epigenetic state. The model reflected status of the tumor-immune-stromal microenvironment and was able to predict patient survival in the majority of cancer types. Our results lay a solid foundation for epigenetic regulation in human cancer and pave a new road for related therapeutic targets.http://link.springer.com/article/10.1186/s13045-020-00854-wm6A regulators5mC regulatorsPan-cancer analysesGenomic alterationsTumor microenvironmentSurvival |
spellingShingle | Yu-Tong Chen Jia-Yi Shen Dong-Ping Chen Chen-Fei Wu Rui Guo Pan-Pan Zhang Jia-Wei Lv Wen-Fei Li Zi-Xian Wang Yu-Pei Chen Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types Journal of Hematology & Oncology m6A regulators 5mC regulators Pan-cancer analyses Genomic alterations Tumor microenvironment Survival |
title | Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types |
title_full | Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types |
title_fullStr | Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types |
title_full_unstemmed | Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types |
title_short | Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types |
title_sort | identification of cross talk between m6a and 5mc regulators associated with onco immunogenic features and prognosis across 33 cancer types |
topic | m6A regulators 5mC regulators Pan-cancer analyses Genomic alterations Tumor microenvironment Survival |
url | http://link.springer.com/article/10.1186/s13045-020-00854-w |
work_keys_str_mv | AT yutongchen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT jiayishen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT dongpingchen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT chenfeiwu identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT ruiguo identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT panpanzhang identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT jiaweilv identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT wenfeili identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT zixianwang identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes AT yupeichen identificationofcrosstalkbetweenm6aand5mcregulatorsassociatedwithoncoimmunogenicfeaturesandprognosisacross33cancertypes |